Research Article
Prognostic Factors of Gliosarcoma in the Real World: A Retrospective Cohort Study
Table 2
Univariable and multivariable analysis according to OS and RFS.
(a) |
| Variable name | Univariable analysis, OS | Multivariable analysis, OS | value | HR (95% CI) | value | HR (95% CI) |
| Age | 0.732 | 1.151 (0.515-2.572) | | | Sex | 0.358 | 0.678 (0.296-1.553) | | | Primary or secondary | 0.749 | 0.850 (0.315-2.298) | | | Primary vs. GBM-origined | 0.317 | 1.742 (0.588–5.166) | | | Primary vs. non-GBM-origined | 0.507 | 0.503 (0.066-3.827) | | | KPS | 0.847 | 0.919 (0.392–2.157) | | | Location | 0.548 | | | | Frontal vs. deep | 0.195 | 0.452 (0.136-1.500) | | | Parietal vs. deep | 0.989 | 0.990 (0.244-4.024) | | | Temporal vs. deep | 0.364 | 0.624 (0.226-1.728) | | | Size | 0.334 | 0.657 (0.280-1.542) | | | Number of lesions | 0.036 | 0.095 (0.011-0.853) | | | Epileptic seizure | 0.684 | 0.739 (0.172-3.170) | | | Intracranial hypertension | 0.377 | 0.639 (0.237-1.725) | | | Ki-67 level | 0.132 | 2.039 (0.807-5.151) | 0.059 | 2.803 (0.963-8.162) | Resection range | 0.125 | 0.382 (0.111-1.306) | 0.023 | 0.192 (0.046-0.797) | Radiotherapy | 0.991 | 0.995 (0.389-2.546) | | | Concurrent TMZ | 0.991 | 0.995 (0.389-2.546) | | | Adjuvant TMZ | 0.742 | 0.860 (0.351-2.110) | | | Gene mutation | | | | | IDH1 | — | — | | | p53 | 0.807 | 0.893 (0.360-2.216) | | | PTEN | 0.809 | 1.221 (0.243-6.122) | | | MGMT | 0.953 | 0.950 (0.173-5.229) | | | 1p/19q codeletion | 0.381 | 2.057 (0.410-10.318) | | | TERT | 0.209 | 47.014 (0.116-18994) | | | BRAF | 0.288 | 2.436 (0.472-12.569) | | | PIK3CA | 0.483 | 2.262 (0.232-22.095) | | | ATRX | 0.165 | 0.483 (0.173-1.349) | | | EGFR | 0.975 | 0.966 (0.111-8.415) | | |
|
|
(b) |
| Variable name | Univariable analysis, RFS | Multivariable analysis, RFS | value | HR (95% CI) | value | HR (95% CI) |
| Age | 0.700 | 1.171 (0.524-2.616) | | | Sex | 0.568 | 0.784 (0.341-1.805) | | | Primary or secondary | 0.715 | 1.202 (0.448-3.228) | | | Primary vs. GBM-origined | 0.417 | 1.566 (0.529-4.636) | | | Primary vs. non-GBM-origined | 0.646 | 0.624 (0.083-4.684) | | | KPS | 0.800 | 0.896 (0.383-2.096) | | | Location | 0.708 | | | | Frontal vs. deep | 0.367 | 0.578 (0.176-1.900) | | | Parietal vs. deep | 0.995 | 1.004 (0.250-4.041) | | | Temporal vs. deep | 0.424 | 0.660 (0.238-1.831) | | | Size | 0.426 | 0.706 (0.300-1.663) | | | Number of lesions | 0.022 | 0.071 (0.007-0.679) | | | Epileptic seizure | 0.857 | 0.875 (0.205-3.731) | | | Intracranial hypertension | 0.513 | 0.714 (0.260-1.958) | | | Ki-67 level | 0.130 | 2.066 (0.809-5.278) | 0.052 | 2.996 (0.992-9.053) | Resection range | 0.137 | 0.395 (0.116-1.345) | 0.022 | 0.181 (0.042-0.782) | Radiotherapy | 0.861 | 0.919 (0.360-2.348) | | | Concurrent TMZ | 0.861 | 0.919 (0.360-2.348) | | | Adjuvant TMZ | 0.631 | 0.804 (0.330-1.959) | | | Gene mutation | | | | | IDH1 | — | — | | | p53 | 0.995 | 0.997 (0.402-2.474) | | | PTEN | 0.745 | 1.307 (0.261-6.550) | | | MGMT | 0.992 | 1.009 (0.184-5.527) | | | 1p/19q codeletion | 0.433 | 1.900 (0.382-9.440) | | | TERT | 0.202 | 49.123 (0.125-19.370) | | | BRAF | 0.270 | 2.529 (0.487-13.134) | | | PIK3CA | 0.838 | 1.252 (0.145-10.817) | | | ATRX | 0.298 | 0.581 (0.209-1.617) | | | EGFR | 0.951 | 1.070 (0.124-9.249) | | |
|
|